Next Article in Journal
Crosstalk during the Carbon–Nitrogen Cycle That Interlinks the Biosynthesis, Mobilization and Accumulation of Seed Storage Reserves
Next Article in Special Issue
Mitochondrial Oxidative Stress—A Causative Factor and Therapeutic Target in Many Diseases
Previous Article in Journal
Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease
Previous Article in Special Issue
Mitochondrial Genomes, Phylogenetic Associations, and SNP Recovery for the Key Invasive Ponto-Caspian Amphipods in Europe
 
 
Article
Peer-Review Record

From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel

Int. J. Mol. Sci. 2021, 22(21), 12031; https://doi.org/10.3390/ijms222112031
by Filipe Cortes-Figueiredo 1,2, Filipa S. Carvalho 1, Ana Catarina Fonseca 3,4, Friedemann Paul 2,5, José M. Ferro 3,4, Sebastian Schönherr 6, Hansi Weissensteiner 6,* and Vanessa A. Morais 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2021, 22(21), 12031; https://doi.org/10.3390/ijms222112031
Submission received: 7 October 2021 / Revised: 28 October 2021 / Accepted: 29 October 2021 / Published: 6 November 2021

Round 1

Reviewer 1 Report

In the manuscript "From forensics to clinical research: expanding the variant calling pipeline for the Precision ID mtDNA Whole Genome Panel" Cortes-Figueiredo and colleagues describe a new pipeline for processing samples sequenced on Ion Torrent sequencing systems with the Precision ID library kit. In particular, the authors suggest an open-source alternative to the popular proprietary Torrent Suite™ Software (TSS).
The study design is rigorous and well conducted however, the convoluted structure of the paper makes it difficult to read and follow the articulated results. Although I believe that the procedure is valid, I would like the authors to discuss more in detail the advantages and disadvantages of the PrecisionCalllerPipeline (PCP) method compared to the existing not-proprietary bioinformatic tools for mtDNA analysis mentioned in the paper.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

In the manuscript, Cortes-Figueiredo et al present their work on a novel pipeline, PCP, to call variants on mtDNA genome. They compare the method with the previous used, and found their method is more powerful. The results are well presented and the conclusion was supported by the data. My concerns is the potential issue of false positive: in the application on 50 clinical samples, the new method detected twice number of variants as its counterpart method, and from the description, I couldn't find a clear message whether the new detected variants are true or false positive. The authors should give some more explanation, and give the guidance in result interpretation considering its future application in real clinical trial. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop